Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1996
09/06/1996CA2247207A1 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
09/06/1996CA2214341A1 Morphogen-induced dentine regeneration
09/06/1996CA2213857A1 A method for expressing modified recombinant proteins in a bacterial system
09/06/1996CA2213734A1 A plasmid for expressing modified recombinant proteins in a bacterial system
09/06/1996CA2213669A1 Transgenic animals as model of psoriasis
09/06/1996CA2213621A1 Antiviral combinations of bch-189 and ritonavir
09/06/1996CA2189358A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives
09/06/1996CA2188575A1 Gene transfer-mediated angiogenesis therapy
09/04/1996EP0729976A1 Reconstituted human antibody against human medulloblastomatous cell
09/04/1996EP0729975A1 Ecdn protein and dna coding for the same
09/04/1996EP0729974A1 Cyclic polypeptide with antibiotic activity and a process for preparation thereof
09/04/1996EP0729972A1 Peptide derivatives of tetrahydronaphthalene
09/04/1996EP0729516A1 Recombinant adenoviruses for gene therapy in cancers
09/04/1996EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
09/04/1996EP0729511A1 Compositions and methods for utilizing conditionally lethal genes
09/04/1996EP0729475A1 Purification of hemoglobin
09/04/1996EP0729460A1 Substituted 5-ring heterocycles, their preparation and their use
09/04/1996EP0729362A1 TRANSDERMAL COMPOSITION OF N- N- 5- 4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-$g(a)-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
09/04/1996EP0729361A1 Method of treating neurological disorders
09/04/1996EP0729360A1 Treatment or prevention of crohn's disease and/or ulcerative colitis
09/04/1996EP0729359A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
09/04/1996EP0729325A1 Osteogenic product and process
09/04/1996EP0729300A1 Novel fas protein and methods of use thereof
09/04/1996EP0644181B1 Amino acid derivative and use thereof
09/04/1996EP0630384A4 Methods and compounds for prevention of graft rejection.
09/04/1996EP0560932B1 Methods and compositions for the suppression of neu mediated transformation
09/04/1996EP0506884B1 Method of delivering molecules into eukaryotic cells
09/04/1996EP0463115B1 Acetylated heterologous polypeptides
09/04/1996EP0458878B1 Monoclonal antibody to novel antigen associated with human tumors
09/04/1996CN1130406A Monoclonal antibody that recognizes interstitial cell surface antigen
09/04/1996CN1130405A Monoclonal antibody that induces apoptosis
09/04/1996CN1130402A Pro-urokinase mutants
09/04/1996CN1130385A Antibiotics 10381V. W. X. Y. Z1, Z2 Pre-B and T
09/04/1996CN1130193A Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor (EGF-R) and its diagnosis and therapeutical use
09/04/1996CN1130028A Method for preparing phycocyan
09/04/1996CN1032693C Growth hormone for hepatocyte
09/03/1996US5552875 Paper delivery apparatus for a duplex printer
09/03/1996US5552558 Retroviral protease inhibiting compounds
09/03/1996US5552537 IgE isoforms and methods of use
09/03/1996US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III)
09/03/1996US5552530 Antibodies that specifically bind to and inhibit human synovial phospholipase A2 type A
09/03/1996US5552529 Particularly interesting new cys-his protein, removal of senescent cells
09/03/1996US5552528 Bovine b-endothelial cell growth factor
09/03/1996US5552524 Anti-obesity proteins
09/03/1996US5552523 Anti-obesity proteins
09/03/1996US5552522 Anti-obesity proteins
09/03/1996US5552521 Process for preparing certain aza cyclohexapeptides
09/03/1996US5552520 Such as somatostatin analogs or bombesin analogs
09/03/1996US5552400 Inhibitors of protease activity
09/03/1996US5552397 Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
09/03/1996US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
09/03/1996US5552390 Phosphorothioate inhibitors of metastatic breast cancer
09/03/1996US5552385 Pharmaceutical formulation
09/03/1996US5552384 Antiherpes compositions and method of use
09/03/1996US5552383 Analgesic, antiinflammatory for wounds
09/03/1996US5552382 Gramicidin as a spermicide against sexual transmission of HIV
09/03/1996US5552381 Recombinantly produced human membrane cofactor protein (MCP) pharmaceutical composition, and method of inhibiting complement activity
09/03/1996US5552313 DNA encoding mouse phosphotriesterase-related protein
09/03/1996US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy
09/03/1996US5552308 CDNA clone of a rat serotonin transporter and protein encoded thereby
09/03/1996US5552304 Polypeptide plasmid vectors for dna sequences
09/03/1996US5552303 DNA encoding epithelium-derived T-cell factor
09/03/1996US5552300 T cell antigen receptor V region proteins and methods of preparation thereof
09/03/1996US5552299 Plasmids and process for producing recombinant desulphatohirudin HV-1 peptides
09/03/1996US5552293 Tumor antigen specific antibody
09/03/1996US5552291 Contacting a sample with monoclonal antibodies secreted by hybridoma cells and detection binding to adenocarcinomas
09/03/1996US5552284 Detection of interleukin-8 receptors by nudeic acid hybridization
09/03/1996US5552271 RXR homodimer formation
09/03/1996US5552161 Low viscosity, highly concentrated surfactant suspension
09/03/1996US5552146 Methods and compositions relating to useful antigens of Moraxella catarrhalis
09/03/1996US5552142 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
09/03/1996CA2076658C Hyperglycemic compositions
09/03/1996CA1338584C Superactive human insulin analogues
09/02/1996CA2170839A1 Bacterial preparations, method for producing same, and their use as vaccines
08/1996
08/29/1996WO1996026286A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
08/29/1996WO1996026285A2 Methods and compositions for administering gene therapy vectors
08/29/1996WO1996026284A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
08/29/1996WO1996026280A1 NOVEL CYSTEINE PROTEASE RELATED TO INTERLEUKIN-1β CONVERTING ENZYME
08/29/1996WO1996026279A1 Human dnase i variants
08/29/1996WO1996026278A1 HUMAN DNase I VARIANTS
08/29/1996WO1996026275A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
08/29/1996WO1996026274A1 Antagonists of interleukin-15
08/29/1996WO1996026273A1 Polypeptides derived from urinastatin having calcium channel blocking activity and their use to delay premature delivery
08/29/1996WO1996026269A1 Thrombin preparation
08/29/1996WO1996026268A1 Transgenically produced antithrombin iii
08/29/1996WO1996026265A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras
08/29/1996WO1996026218A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)
08/29/1996WO1996026217A1 Novel protein and methods for the production of the same
08/29/1996WO1996026215A1 Ingap protein involved in pancreatic islet neogenesis
08/29/1996WO1996026214A1 Isolated nonapeptides presented by hla molecules, and uses thereof
08/29/1996WO1996026179A1 Novel cationic lipids and the use thereof
08/29/1996WO1996025949A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
08/29/1996WO1996025946A1 HOMOLOGY OF INTERLEUKIN-1β-CONVERTASE WITH C. ELEGANS CED-3 AND INHIBITION OF CELL DEATH
08/29/1996WO1996025945A1 ISOFORMS OF HUMAN INTERLEUKIN-1β CONVERTING ENZYME AND METHODS OF USING THE SAME
08/29/1996WO1996025944A1 Remedies for arthrosis deformans and inflammatory joint diseases
08/29/1996WO1996025943A1 Compositions and methods for enhancing the growth of hair and restoring hair color
08/29/1996WO1996025942A1 Cochleate phospholipids in drug delivery
08/29/1996WO1996025941A1 Modulators of regulatory proteins
08/29/1996WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996WO1996019580A3 Telomerase protein component
1 ... 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 ... 3163